Harrow, Inc. Earnings Per Share, Basic and Diluted
Harrow, Inc. (HROW) reported Earnings Per Share, Basic and Diluted of -$0.69 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-10
- Harrow, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.11.
- Harrow, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.01.
- Harrow, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.45.
- Harrow, Inc. earnings per share, basic and diluted for the quarter ending 2018-09-30 was -$0.12.
- Harrow, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.69.
- Harrow, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.13.
- Harrow, Inc. earnings per share, basic and diluted for fiscal 2017 was $0.60.
- Harrow, Inc. earnings per share, basic and diluted for fiscal 2016 was -$1.50.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.69 10-K · filed 2022-03-10 | |||||||
| 2021-06-30 | -$0.11 10-Q · filed 2021-08-10 | -$0.10 10-Q · filed 2021-08-10 | ||||||
| 2020-12-31 | -$0.13 10-K · filed 2022-03-10 | |||||||
| 2020-06-30 | -$0.01 10-Q · filed 2021-08-10 | -$0.51 10-Q · filed 2021-08-10 | ||||||
| 2019-09-30 | -$0.45 10-Q · filed 2019-11-13 | -$0.10 10-Q · filed 2019-11-13 | ||||||
| 2018-09-30 | -$0.12 10-Q · filed 2019-11-13 | -$0.16 10-Q · filed 2019-11-13 | ||||||
| 2018-03-31 | -$0.17 10-Q · filed 2018-05-15 | |||||||
| 2017-12-31 | $0.60 10-K · filed 2018-03-08 | |||||||
| 2017-09-30 | -$0.28 10-Q · filed 2018-11-13 | -$0.47 10-Q · filed 2018-11-13 | ||||||
| 2017-03-31 | -$0.26 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | -$1.50 10-K · filed 2018-03-08 | |||||||
| 2016-09-30 | -$0.29 10-Q · filed 2017-11-14 | -$1.05 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | -$0.35 10-Q · filed 2016-08-15 | -$0.77 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | -$0.43 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | -$1.66 10-K · filed 2017-03-21 | |||||||
| 2015-09-30 | -$0.41 10-Q · filed 2016-11-14 | -$1.13 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | -$0.39 10-Q · filed 2016-08-15 | -$0.72 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | -$0.33 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2016-03-23 | -$0.56 derived: net income ÷ weighted average shares · filed 2016-03-23 | -$0.85 derived: net income ÷ weighted average shares · filed 2016-03-23 | -$1.11 10-K · filed 2016-03-23 | ||||
| 2014-09-30 | -$0.27 10-Q · filed 2015-11-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.81 10-Q · filed 2015-11-12 | -$1.02 derived: net income ÷ weighted average shares · filed 2015-11-12 | ||||
| 2014-06-30 | -$0.28 10-Q · filed 2015-08-12 | -$0.54 10-Q · filed 2015-08-12 | -$0.75 derived: net income ÷ weighted average shares · filed 2015-08-12 | -$0.99 derived: net income ÷ weighted average shares · filed 2015-08-12 | ||||
| 2014-03-31 | -$0.26 10-Q · filed 2015-05-13 | -$0.47 derived: net income ÷ weighted average shares · filed 2015-05-13 | -$0.70 derived: net income ÷ weighted average shares · filed 2015-05-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2015-05-13 | ||||
| 2013-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.44 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.88 10-K · filed 2015-03-12 | ||||
| 2013-09-30 | -$0.23 10-Q · filed 2014-11-12 | -$0.48 derived: net income ÷ weighted average shares · filed 2014-11-12 | -$0.67 10-Q · filed 2014-11-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2014-11-12 | ||||
| 2013-06-30 | -$0.25 10-Q · filed 2014-08-13 | -$0.44 10-Q · filed 2014-08-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2014-08-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2014-08-13 | ||||
| 2013-03-31 | -$0.19 10-Q · filed 2014-05-15 | -$0.40 derived: net income ÷ weighted average shares · filed 2014-05-15 | -$0.60 derived: net income ÷ weighted average shares · filed 2014-05-15 | -$0.92 derived: net income ÷ weighted average shares · filed 2014-05-15 | ||||
| 2012-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$0.41 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$0.75 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$1.24 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | -$0.20 10-Q · filed 2013-11-06 | -$0.04 10-Q · filed 2012-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2013-11-06 | -$1.11 10-Q · filed 2013-11-06 | -$0.22 10-Q · filed 2012-11-14 | -$2.66 derived: net income ÷ weighted average shares · filed 2013-11-06 | ||
| 2012-06-30 | -$0.39 10-Q · filed 2013-08-14 | -$0.08 10-Q · filed 2012-08-14 | -$1.17 10-Q · filed 2013-08-14 | -$0.23 10-Q · filed 2012-08-14 | -$17.43 derived: net income ÷ weighted average shares · filed 2013-08-14 | -$5.25 derived: net income ÷ weighted average shares · filed 2013-08-14 | ||
| 2012-03-31 | -$1.30 10-Q · filed 2013-05-08 | -$0.26 10-Q · filed 2012-05-10 | $1.06 derived: net income ÷ weighted average shares · filed 2013-05-08 | $4.15 derived: net income ÷ weighted average shares · filed 2013-05-08 | ||||
| 2011-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2013-03-18 | $0.38 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$2.65 10-K · filed 2013-03-18 | -$0.07 10-K · filed 2012-02-23 | ||||
| 2011-09-30 | -$0.04 10-Q · filed 2012-11-14 | -$0.01 10-Q · filed 2012-02-23 | -$0.34 10-Q · filed 2012-11-14 | -$0.04 10-Q · filed 2012-02-23 | ||||
| 2011-06-30 | -$0.08 10-Q · filed 2012-08-14 | -$0.01 10-Q · filed 2012-02-23 | -$0.30 10-Q · filed 2012-08-14 | -$0.04 10-Q · filed 2012-02-23 | ||||
| 2011-03-31 | -$0.22 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | -$0.16 10-K · filed 2012-02-23 | |||||||
| 2010-09-30 | -$0.05 10-Q · filed 2012-02-23 | -$0.13 10-Q · filed 2012-02-23 | ||||||
| 2010-06-30 | -$0.03 10-Q · filed 2012-02-23 | -$0.09 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |